Seelos Therapeutics, Inc. (SEEL)
NASDAQ: SEEL · IEX Real-Time Price · USD
0.546
+0.022 (4.28%)
At close: Jul 19, 2024, 4:00 PM
0.540
-0.006 (-1.08%)
Pre-market: Jul 22, 2024, 7:21 AM EDT

Seelos Therapeutics Stock Forecast

SEEL's stock price has decreased by -99.86% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Seelos Therapeutics stock has a target of 240, which predicts an increase of 43,864.10% from the current stock price of 0.55.

Analyst Consensus: Hold
Target Low Average Median High
Price $240 $240 $240 $240
Change +43864.1% +43864.1% +43864.1% +43864.1%
* Price targets were last updated on Sep 21, 2023.

Analyst Ratings

The average analyst rating for SEEL stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 111110
Buy 111111
Hold 222222
Sell 000000
Strong Sell 000000
Total 444443

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 22, 2023
Benchmark
Benchmark
Buy
Maintains
$960$240
Buy Maintains $960$240 +43,864.10% Sep 21, 2023
Guggenheim
Guggenheim
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 21, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 21, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$480
Buy Reiterates $480 +87,828.19% Aug 22, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
306.00K
from 2.20M
Decreased by -86.11%
Revenue Next Year
28.97M
from 306.00K
Increased by 9,366.67%
EPS This Year
-1.34
from -61.84
EPS Next Year
-0.33
from -1.34
Year 2019202020212022202320242025
Revenue
375.00K---2.20M306.00K28.97M
Revenue Growth
------86.11%9,366.67%
EPS
-604.80-103.20-175.20-165.92-61.84-1.34-0.33
EPS Growth
-------
Forward PE
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 945,000 29.8M
Avg 306,000 29.0M
Low n/a 27.8M

Revenue Growth

Revenue Growth 20242025
High
-57.1%
9,645.1%
Avg
-86.1%
9,366.7%
Low -
8,995.4%

EPS Forecast

EPS 20242025
High -1.38 -0.34
Avg -1.34 -0.33
Low -1.28 -0.31

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.